BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35789495)

  • 21. Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12.
    Singh AK; Arya RK; Trivedi AK; Sanyal S; Baral R; Dormond O; Briscoe DM; Datta D
    Cytokine Growth Factor Rev; 2013 Feb; 24(1):41-9. PubMed ID: 22989616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of chemokine (CXC motif) ligand 12/chemokine (CXC motif) receptor 4 axis (CXCL12/CXCR4)-mediated cell migration by targeting mammalian target of rapamycin (mTOR) pathway in human gastric carcinoma cells.
    Chen G; Chen SM; Wang X; Ding XF; Ding J; Meng LH
    J Biol Chem; 2012 Apr; 287(15):12132-41. PubMed ID: 22337890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of chemokine receptors in breast cancer metastasis.
    Müller A; Homey B; Soto H; Ge N; Catron D; Buchanan ME; McClanahan T; Murphy E; Yuan W; Wagner SN; Barrera JL; Mohar A; Verástegui E; Zlotnik A
    Nature; 2001 Mar; 410(6824):50-6. PubMed ID: 11242036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis.
    Mochizuki H; Matsubara A; Teishima J; Mutaguchi K; Yasumoto H; Dahiya R; Usui T; Kamiya K
    Biochem Biophys Res Commun; 2004 Jul; 320(3):656-63. PubMed ID: 15240098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of the nuclear factor-κB signaling pathway in the regulation of CXC chemokine receptor-4 expression in neuroblastoma cells induced by tumor necrosis factor-α.
    Zhi Y; Lu H; Duan Y; Sun W; Guan G; Dong Q; Yang C
    Int J Mol Med; 2015 Feb; 35(2):349-57. PubMed ID: 25503960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of a CXCR4 antagonist in a xenograft mouse model of inflammatory breast cancer.
    Singh B; Cook KR; Martin C; Huang EH; Mosalpuria K; Krishnamurthy S; Cristofanilli M; Lucci A
    Clin Exp Metastasis; 2010 Apr; 27(4):233-40. PubMed ID: 20229045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human melanoma metastases express functional CXCR4.
    Scala S; Giuliano P; Ascierto PA; Ieranò C; Franco R; Napolitano M; Ottaiano A; Lombardi ML; Luongo M; Simeone E; Castiglia D; Mauro F; De Michele I; Calemma R; Botti G; Caracò C; Nicoletti G; Satriano RA; Castello G
    Clin Cancer Res; 2006 Apr; 12(8):2427-33. PubMed ID: 16638848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CXC chemokine receptor CXCR4 expression enhances tumorigenesis and angiogenesis of basal cell carcinoma.
    Chen GS; Yu HS; Lan CC; Chow KC; Lin TY; Kok LF; Lu MP; Liu CH; Wu MT
    Br J Dermatol; 2006 May; 154(5):910-8. PubMed ID: 16634895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CXCL14 antagonizes the CXCL12-CXCR4 signaling axis.
    Hara T; Tanegashima K
    Biomol Concepts; 2014 May; 5(2):167-73. PubMed ID: 25372750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression.
    Jiang YP; Wu XH; Shi B; Wu WX; Yin GR
    Gynecol Oncol; 2006 Oct; 103(1):226-33. PubMed ID: 16631235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. X4 HIV-1 induces neuroblastoma cell death by interference with CXCL12/CXCR4 interaction.
    Hatse S; Bridger G; de Clercq E; Schols D
    Cell Mol Biol (Noisy-le-grand); 2003; 49 Online Pub():OL443-52. PubMed ID: 14995074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical importance and therapeutic implications of the pivotal CXCL12-CXCR4 (chemokine ligand-receptor) interaction in cancer cell migration.
    Arya M; Ahmed H; Silhi N; Williamson M; Patel HR
    Tumour Biol; 2007; 28(3):123-31. PubMed ID: 17510563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Murine B16 melanomas expressing high levels of the chemokine stromal-derived factor-1/CXCL12 induce tumor-specific T cell chemorepulsion and escape from immune control.
    Vianello F; Papeta N; Chen T; Kraft P; White N; Hart WK; Kircher MF; Swart E; Rhee S; Palù G; Irimia D; Toner M; Weissleder R; Poznansky MC
    J Immunol; 2006 Mar; 176(5):2902-14. PubMed ID: 16493048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activating and inhibitory Ly49 receptors modulate NK cell chemotaxis to CXC chemokine ligand (CXCL) 10 and CXCL12.
    Inngjerdingen M; Rolstad B; Ryan JC
    J Immunol; 2003 Sep; 171(6):2889-95. PubMed ID: 12960311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epithelial chemokine CXCL14 synergizes with CXCL12
    Collins PJ; McCully ML; Martínez-Muñoz L; Santiago C; Wheeldon J; Caucheteux S; Thelen S; Cecchinato V; Laufer JM; Purvanov V; Monneau YR; Lortat-Jacob H; Legler DF; Uguccioni M; Thelen M; Piguet V; Mellado M; Moser B
    FASEB J; 2017 Jul; 31(7):3084-3097. PubMed ID: 28360196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer.
    Nazari A; Khorramdelazad H; Hassanshahi G
    Int J Clin Oncol; 2017 Dec; 22(6):991-1000. PubMed ID: 29022185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic and Predictive Role of CXC Chemokine Receptor 4 in Metastatic Colorectal Cancer Patients.
    Ottaiano A; Scala S; Normanno N; Botti G; Tatangelo F; Di Mauro A; Capozzi M; Facchini S; Tafuto S; Nasti G
    Appl Immunohistochem Mol Morphol; 2020; 28(10):755-760. PubMed ID: 31985548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CXCR4-Targeted Necrosis-Inducing Peptidomimetic for Treating Breast Cancer.
    Akonnor A; Makise M; Kuniyasu A
    ACS Omega; 2023 Jul; 8(27):24467-24476. PubMed ID: 37457445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CXCL12 induces tyrosine phosphorylation of cortactin, which plays a role in CXC chemokine receptor 4-mediated extracellular signal-regulated kinase activation and chemotaxis.
    Luo C; Pan H; Mines M; Watson K; Zhang J; Fan GH
    J Biol Chem; 2006 Oct; 281(40):30081-93. PubMed ID: 16905744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies.
    Khare T; Bissonnette M; Khare S
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.